Follow-The-Filings

Security · featured owners

ANRO Alto Neuroscience Inc.

Health Care COM SHS Equity as of 2026 Q2 among managers we track

  • 1 exit

ANRO (Alto Neuroscience Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Polen Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 16,613 $373K history

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Net income -$61.43M -$63.24M

Balance sheet

Metric FY2024 FY2025
Total current assets $169.34M $177.72M
Total non-current assets * $8.2M $6.97M
Total assets $177.54M $184.69M
Total current liabilities $10.01M $11.32M
Total non-current liabilities * $16.07M $22.22M
Total equity $151.46M $151.14M

Cash flow

Metric FY2024 FY2025
Cash from operations -$47.42M -$51.77M
Cash from investing -$2.08M -$0.024M
Cash from financing $135.69M $60.08M
Net change in cash $86.18M $8.26M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders